Article
Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes.
Pediatric diabetes - 1 Jun 2015
Chase H Peter, Boulware David, Rodriguez Henry, Donaldson David, Chritton Sonia, Rafkin-Mervis Lisa, Krischer Jeffrey, Skyler Jay S, Clare-Salzler Michael
Abstract excerpt
OBJECTIVE: Type 1 diabetes (T1D) results from the inflammatory destruction of pancreatic β-cells. In this study, we investigated the effect of docosahexaenoic acid (DHA) supplementation on stimulated inflammatory cytokine production in white blood cells (WBC) from infants with a high genetic risk for T1D. RESEARCH DESIGN AND METHODS: This was a multicenter, two-arm, randomized, double-blind pilot trial of DHA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
